Regulatory hurdles outpace intelligence gains in medical AI
August 5, 2026
Intelligence alone is not the primary bottleneck for AI progress in sectors like medicine; instead, regulatory frameworks and clinical trial requirements remain the core constraints. Advances in pre-clinical research do not solve the friction caused by unsexy, slow-moving policy structures.
HOW THIS AFFECTS YOU
●
founderWhen building in highly regulated verticals, focus on navigating compliance and trials rather than just model performance.
●
policyPolicy makers must address the gap between rapid model scaling and the slow pace of clinical validation.